Skip to main content
AV

Avivomed

Minneapolis, United States
Last funding
$32.0M
Series ADec 2021

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

About Avivomed

How much funding has Avivomed raised?

Avivomed has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Where is Avivomed headquartered?

Avivomed is headquartered in Minneapolis, United States.

What does Avivomed do?

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

What stage is Avivomed at?

Avivomed is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Avivomed — Funding & Investors." VCBacked, December 1, 2021, https://www.vcbacked.co/company/avivomed. Accessed November 18, 2026.
APA
VCBacked. (2021). Avivomed — Funding & Investors. Retrieved November 18, 2026, from https://www.vcbacked.co/company/avivomed
Wikipedia (cite web)
{{cite web |title=Avivomed — Funding & Investors |url=https://www.vcbacked.co/company/avivomed |website=VCBacked |access-date=November 18, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Avivomed? Request a listing update

Founder contacts
m***@avivomed.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →